| Dr Robert Wayne Besinger, MD | |
|
205a Belle Meade Pt, Flowood, MS 39232-3311 | |
| (601) 200-5678 | |
| (601) 992-0096 |
| Full Name | Dr Robert Wayne Besinger |
|---|---|
| Gender | Male |
| Speciality | Pediatrics |
| Location | 205a Belle Meade Pt, Flowood, Mississippi |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1497042030 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208000000X | Pediatrics | T-2406 (Mississippi) | Secondary |
| 208000000X | Pediatrics | 23259 (Mississippi) | Primary |
| Entity Name | St. Dominic Medical Associates Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1407920549 PECOS PAC ID: 0446303168 Enrollment ID: O20090728000821 |
News Archive
CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Cancer is a group of more than 100 different diseases. All are driven by cells and genes that escape the normal process of division and begin their own plan to replicate in the body.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Robert Wayne Besinger, MD 5959 S Sherwood Forest Blvd, Baton Rouge, LA 70816-6038 Ph: (601) 200-5678 | Dr Robert Wayne Besinger, MD 205a Belle Meade Pt, Flowood, MS 39232-3311 Ph: (601) 200-5678 |
News Archive
CVRx, Inc. reported the first enrollment of a patient in the HOPE4HF Trial, a study that is evaluating the Rheos System to treat heart failure. The Rheos System uses Baroreflex Activation Therapy® technology, an entirely new non-pharmaceutical approach designed to treat cardiovascular disease. The HOPE4HF Trial is being conducted under an approved investigational device exemption (IDE) from the U.S. Food and Drug Administration (FDA).
The National Institutes of Health (NIH) has awarded researchers at Albert Einstein College of Medicine at Yeshiva University a five-year, $5.9 million grant to develop a new vaccine against tuberculosis (TB), including the toughest-to-treat forms of the disease known as multi drug-resistant and extensively drug-resistant. The grant will build on a new approach to TB vaccine design that is based on genetically altered Mycobacterium smegmatis, which is closely related to the bacterial species (Mycobacterium tuberculosis) that causes TB in humans.
Cancer is a group of more than 100 different diseases. All are driven by cells and genes that escape the normal process of division and begin their own plan to replicate in the body.
The study, which looked at Medicare records of more than 130,000 women, found that those who underwent the faster treatment, called brachytherapy, were about twice as likely to have a mastectomy in the following five years -;
› Verified 8 days ago
Dr. Samuel A. Smith, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 | |
David M Temple, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
David F Wender, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-975-7345 Fax: 769-251-5429 | |
Dr. Alisha Stockton Vaughn, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 151 E Metro Dr, Suite 102, Flowood, MS 39232 Phone: 601-992-2292 | |
Dr. Megan Lynn Washington, D.O. Pediatrics Medicare: Medicare Enrolled Practice Location: 1020 River Oaks Dr, Ste 100, Flowood, MS 39232 Phone: 601-326-8700 Fax: 601-936-2252 | |
Carold Jason Miller, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5 River Bend Place, Suite C, Flowood, MS 39232 Phone: 601-957-7345 Fax: 769-251-5429 | |
Dr. Laura A. Barron, M.D. Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 2946 Layfair Drive, Flowood, MS 39232 Phone: 601-420-8233 Fax: 601-936-5370 |